The Gerstner Sloan Kettering faculty brings together outstanding scientists working at the forefront of biomedical research. Browse our Research and Faculty and learn more about each faculty member’s area of investigation.

Faculty members who do not serve as dissertation mentors but who make contributions to the education of our students by teaching or serving as clinical mentors are appointed as Gerstner Sloan Kettering Special Contributing Faculty.


126 Faculty Members found

Michelle S. Bradbury, MD, PhD

PhD – Massachusetts Institute of Technology, Cambridge, MA
MD – George Washington University, School of Medicine, Washington, DC

Pictured: Dr. Michelle Bradbury

Clinician-scientist Michelle Bradbury develops translational, tumor-targeting, PET-optical silica nanoparticle probes for diagnostics, drug delivery, and sensing.

Renier J. Brentjens, MD, PhD

Associate Professor
MD, PhD, The State University of New York at Buffalo, School of Medicine and Biomedical Sciences

Pictured: Renier J. Brentjens

Physician-scientist Renier Brentjens develops novel immunotherapies for leukemias and lymphomas.

Raju Chaganti, PhD

PhD, Harvard University

Pictured: Raju Chaganti

Geneticist Raju Chaganti studies genomic instability in cancer cells and its implications for clinical behavior of tumors and normal cellular developmental pathways.

Timothy A. Chan, MD, PhD

MD, PhD, The Johns Hopkins University School of Medicine

Pictured: Timothy Chan

Physician-scientist Timothy Chan focuses on the characterization of genetic determinants underlying response and resistance to cancer therapeutics.

Sarat Chandarlapaty, MD, PhD

Associate Professor
MD, Wake Forest School of Medicine
PhD, University of North Carolina

Pictured: Sarat Chandarlapaty

Physician-scientist Sarat Chandarlapaty studies the regulation of growth factor signaling networks in cancer.

Yu Chen, MD, PhD

Assistant Professor
MD, Weill Cornell Medical College
PhD, The Rockefeller University

Pictured: Yu Chen

Physician-scientist Yu Chen studies the role of transcription factors that are critical for prostate cancer development.

Emily H. Cheng, MD, PhD

MD, Taipei Medical University
PhD, Johns Hopkins University School of Medicine

Emily H. Cheng, MD, PhD

Physician-scientist Emily Cheng focuses on the molecular mechanisms of cell death and their implications in tumorigenesis and cancer therapy, with primary emphasis on lung and kidney cancers.

Nai-Kong V. Cheung, MD, PhD

MD, PhD (Immunology), Harvard Medical School

The Nai-Kong Cheung Lab

Physician-scientist Nai-Kong Cheung focuses on engineering antibodies and immune cells to treat both solid tumors and liquid tumors in children.

Ping Chi, MD, PhD

Associate Professor
MD, Weill Cornell Medical College
PhD, The Rockefeller University

Pictured: Ping Chi

Physician-scientist Ping Chi studies genetic and epigenetic mechanisms of transcriptional regulation by oncogenic factors in GIST, MPNST, melanoma and other solid tumors.